As the market for transcatheter valve devices continues to grow, structural heart devices have become one of Medtronic’s strengths.
Sales of its transcatheter valves grew 11% globally in the first quarter of fiscal 2024 (calendar May to July 2023), led by rapid adoption of Evolut FX, the fourth generation...